Aehr Test Systems Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results

Aehr Test Systems Issues Fiscal Year 2026 Results Announcement

Aehr Test Systems formally announced on July 14, 2026, that it had released its financial results covering the fourth quarter and the full fiscal year ended May 29, 2026. The company, incorporated in California and listed on the NASDAQ Capital Market under the ticker symbol AEHR, made the announcement through a current report filed with securities regulators on that same date. Aehr Test Systems is headquartered at 400 Kato Terrace, Fremont, California, 94539.

The current report identified the press release as Exhibit 99.1, furnished alongside the disclosure. The filing confirms that the company's fiscal year conclusion date was May 29, 2026, establishing the precise accounting period covered by the results being communicated to investors and the broader market on that date.

Scope of the Fiscal 2026 Results Disclosure

The current report states that the press release announced the company's financial results for its fourth quarter and fiscal year ended May 29, 2026. The report itself, as filed with regulators, does not reproduce specific revenue figures, earnings data, or operational metrics. Those details are contained exclusively within Exhibit 99.1, the press release furnished with the current report.

The company did not disclose specific financial figures within the body of the current report itself. Investors seeking detailed financial metrics, including revenue, net income, earnings per share, or any forward-looking guidance, would need to refer directly to Exhibit 99.1 as referenced in the filing. The current report functions as a formal regulatory notification that such results have been released, rather than a standalone financial summary.

About Aehr Test Systems and Its Business Operations

Aehr Test Systems is a California corporation engaged in the design, engineering, and manufacture of semiconductor test and burn-in equipment. The company's products are used in the testing and reliability screening of semiconductor devices, a process critical to ensuring the quality and longevity of chips used across a range of end applications. Aehr Test Systems has established itself as a provider of wafer-level burn-in and test systems, which enable semiconductor manufacturers to identify and eliminate defective devices before they reach end markets.

The company's common stock has a par value of $0.01 per share and is listed on the NASDAQ Capital Market under the ticker symbol AEHR. Aehr Test Systems operates under IRS Employer Identification Number 94-2424084, with Commission File Number 000-22893 assigned by regulators. The company's principal executive offices are located in Fremont, California, and it maintains a telephone number of 510-623-9400 as its registrant contact line, as stated in the filing.

Legal Status of the Furnished Exhibit Under Securities Law

The filing explicitly notes that the information contained in Item 2.02 and in Exhibit 99.1 is "furnished" rather than "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. This distinction carries meaningful legal implications for how the information is treated under securities law. Furnished materials are generally not subject to the same liability provisions that apply to information formally filed with regulators.

Specifically, the current report states that the furnished information shall not be deemed subject to the liabilities of Section 18 of the Exchange Act, nor to Sections 11 and 12(a)(2) of the Securities Act of 1933. The filing further specifies that the information in Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any other filing under the Securities Act or the Exchange Act, except where expressly set forth by specific reference in such a filing.

Signatory and Authorization of the Filing

The current report was signed on July 14, 2026, by Chris P. Siu, who holds the titles of Executive Vice President of Finance and Chief Financial Officer at Aehr Test Systems. The filing states that the registrant duly authorized Mr. Siu to sign the report on its behalf pursuant to the requirements of the Securities Exchange Act of 1934. His signature appears as "/s/ Chris P. Siu" in the filing.

The CFO's authorization of the disclosure is consistent with standard regulatory practice, whereby a senior financial officer attests to the completeness and proper execution of a current report announcing financial results. No other signatories are listed in the current report, and the filing does not contain additional management commentary or operational statements beyond what is described in Item 2.02.

Emerging Growth Company Status Confirmed as Not Applicable

The current report includes a disclosure confirming that Aehr Test Systems does not qualify as an emerging growth company as defined under Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. This determination was indicated by the company's check-box selection within the filing's cover page, where the "emerging growth company" checkbox is marked as not applicable.

Because Aehr Test Systems is not an emerging growth company, it is not eligible to use the extended transition period for complying with new or revised financial accounting standards under Section 13(a) of the Exchange Act. This status is disclosed as part of the standard cover page requirements for current reports and confirms the company's regulatory classification at the time of the filing.

Exhibit Structure and Cover Page Interactive Data

The current report lists two exhibits in Item 9.01. The first is Exhibit 99.1, described as the "Press Release dated July 14, 2026, announcing the Company's fiscal 2026 fourth quarter financial results." This exhibit constitutes the primary vehicle through which Aehr Test Systems communicated its financial outcomes for the relevant reporting period to investors and regulatory recipients.

The second exhibit listed is Exhibit 104, described as the "Cover Page Interactive Data File (embedded within the Inline XBRL document)." XBRL, or Extensible Business Reporting Language, is a standardized format used in regulatory filings to allow structured, machine-readable financial data. The inclusion of an embedded Inline XBRL cover page data file is consistent with current regulatory requirements applicable to NASDAQ-listed companies submitting current reports.

Fiscal Year End Date and Reporting Period Defined

The filing establishes that Aehr Test Systems operates on a fiscal year calendar that concluded on May 29, 2026. This non-standard fiscal year end date, which differs from the typical December 31 calendar year end used by many publicly listed companies, means that the company's annual and quarterly reporting cycles are aligned to this May-end schedule. The fourth quarter covered in the results announcement therefore corresponds to the period ending May 29, 2026.

The company did not disclose the specific start date of its fourth quarter within the current report, nor did it provide interim period comparisons or prior-year references within the body of this particular regulatory update. Those details, if disclosed at all, would be contained within Exhibit 99.1, the press release that accompanies the filing as a furnished exhibit.

No Solicitation or Communications Checkbox Items Checked

As part of the standard current report cover page, Aehr Test Systems confirmed that the filing was not intended to satisfy any written communications obligation under Rule 425 of the Securities Act, any soliciting material obligation under Rule 14a-12 of the Exchange Act, or any pre-commencement communications obligation under Rule 14d-2(b) or Rule 13e-4(c) of the Exchange Act. All four applicable checkboxes on the cover page were marked as unchecked in the filing.

This is a standard procedural confirmation routinely included in current reports and does not reflect any unusual regulatory circumstance specific to this particular filing. It confirms that the current report was filed solely in connection with the announcement of financial results under Item 2.02, without any additional transactional or solicitation context attached to the disclosure.

Common Stock Listing Details on NASDAQ Capital Market

The filing confirms that Aehr Test Systems' common stock, carrying a par value of $0.01 per share, is registered under Section 12(b) of the Securities Exchange Act and listed on the NASDAQ Capital Market under the trading symbol AEHR. This listing detail appears in the Securities Registered section of the current report's cover page and establishes the regulatory framework under which the company's equity securities trade.

The immediate share price impact of this results announcement was not clear from available public information at the time of the filing. The current report itself does not reference any share price movement, trading volume, or market reaction. Investors monitoring Aehr Test Systems' equity performance would need to consult publicly available market data sources to assess any price activity associated with the fiscal 2026 results announcement.